leisure time -WSS

leisure time

author：hotspot 2025-09-03 03:43:23 - browse：1

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： When waiting feels immoral: Empathy in the emergency department

focus

WSS

Readout Newsletter: New research from Sanofi, Regeneron, etc.

H.R. 3 is the wrong path to lower drug costs

H.R. 3 is the wrong path to lower drug costs

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Medicare slashes safety net hospital payments by nearly $1 billion

Emergency medicine has repudiated 'excited delirium.' Now what?

hotspot

leisure time

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Emergency medicine has repudiated 'excited delirium.' Now what?

Activists slam private health insurers over coverage restrictions

The pink breast cancer awareness ribbon needs a redesign

DIEP, the 'gold standard' of breast reconstruction, is under threat

Testing for cancer recurrence creates a new limbo for patients

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA has safety concerns on CRISPR

Psychedelics group wrestles with new pharma identity

2 officers injured in shooting in Orlando, police say

focus

Alnylam reports growth in sales of rare disease treatments

Testing for cancer recurrence creates a new limbo for patients

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

CDC recommends rationing of RSV shot due to shortages

Readout Newsletter: New research from Sanofi, Regeneron, etc.

The cancer stories no one wants to hear

focus

focus

knowledge

hotspot